Update on the genetics of the fibromyalgia syndrome.

Fibromyalgia syndrome (FMS), a condition characterized by chronic widespread pain and tenderness, is a complex condition considered to represent a paradigm of centralized pain. FMS has demonstrated a clear familial aggregation, and hence it is considered to have a genetic background. Multiple candidate-gene studies have been conducted in this field, focusing on target genes that play a role in the transmission and processing of pain. While many of these have focused in the past on markers related to neurotransmitter systems such as catecholamines (catechol-O-methyltransferase (COMT)) and serotonin, novel target genes have recently emerged. In addition, genome-wide sequencing scanning (genome-wide association study (GWAS)) is increasingly being harnessed for the study of chronic pain, including FMS. Micro RNAs are another novel field of research related to posttranscriptional inhibition of gene expression, which are currently regarding the pathogenesis of FMS.

[1]  D. Zaykin,et al.  Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. , 2012, Arthritis and rheumatism.

[2]  M. Yaron,et al.  Candidate-gene approach in fibromyalgia syndrome: association analysis of the genes encoding substance P receptor, dopamine transporter and alpha1-antitrypsin. , 2009, Clinical and experimental rheumatology.

[3]  P. Keck,et al.  Family study of fibromyalgia. , 2004, Arthritis and rheumatism.

[4]  M. Farquhar,et al.  The regulator of G protein signaling family. , 2000, Annual review of pharmacology and toxicology.

[5]  Daniel J Clauw,et al.  Fibromyalgia: a clinical review. , 2014, JAMA.

[6]  W. Thomson,et al.  Genetic variation in neuroendocrine genes associates with somatic symptoms in the general population: Results from the EPIFUND study , 2010, Journal of psychosomatic research.

[7]  R. Ebstein,et al.  The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158) met and fibromyalgia. , 2009, Clinical and experimental rheumatology.

[8]  E. Madenci,et al.  Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome , 2003, Rheumatology International.

[9]  H. Ursin,et al.  Altered dopamine D2 receptor function in fibromyalgia patients: a neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls. , 2003, Journal of affective disorders.

[10]  H. Richter,et al.  Anandamide and neutrophil function in patients with fibromyalgia , 2008, Psychoneuroendocrinology.

[11]  Robert R. Edwards,et al.  Polymorphisms in the GTP cyclohydrolase gene (GCH1) are associated with ratings of capsaicin pain , 2009, PAIN®.

[12]  M. Gratacós,et al.  Genome-wide analysis of single nucleotide polymorphisms and copy number variants in fibromyalgia suggest a role for the central nervous system , 2014, PAIN®.

[13]  M. Blanco,et al.  TRP channels as emerging targets for pain therapeutics , 2009, Expert opinion on therapeutic targets.

[14]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[15]  Daniel J Clauw,et al.  Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. , 2008, Arthritis and rheumatism.

[16]  D. Clauw,et al.  From fibrositis to functional somatic syndromes to a bell-shaped curve of pain and sensory sensitivity: evolution of a clinical construct. , 2009, Rheumatic diseases clinics of North America.

[17]  L. Arnold,et al.  The fibromyalgia family study: a genome-wide linkage scan study. , 2013, Arthritis and rheumatism.

[18]  Teri A Manolio,et al.  Genomewide association studies and assessment of the risk of disease. , 2010, The New England journal of medicine.

[19]  D. Buskila,et al.  Personalized Treatment of Pain , 2012, Current Rheumatology Reports.

[20]  R. Bojalil,et al.  Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia , 2007, Arthritis research & therapy.

[21]  I. Russell,et al.  Genetic Polymorphisms of the ß2-Adrenergic Receptor Relate to Guanosine Protein-coupled Stimulator Receptor Dysfunction in Fibromyalgia Syndrome , 2011, The Journal of Rheumatology.

[22]  F. Wolfe,et al.  Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. , 1997, The Journal of rheumatology.

[23]  Michael Gill,et al.  Confirming RGS4 as a susceptibility gene for schizophrenia , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[24]  A. Tammimäki,et al.  Catechol-O-methyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis , 2012, Pharmacogenetics and genomics.

[25]  M. Narita,et al.  Temporomandibular disorder is associated with a serotonin transporter gene polymorphism in the Japanese population , 2007, BioPsychoSocial medicine.

[26]  F. M. de Andrade,et al.  Influence of the interaction between environmental quality and T102C SNP in the HTR2A gene on fibromyalgia susceptibility. , 2011, Revista brasileira de reumatologia.

[27]  Blair H. Smith,et al.  Genetic variation in the beta2-adrenergic receptor but not catecholamine-O-methyltransferase predisposes to chronic pain: Results from the 1958 British Birth Cohort Study , 2010, PAIN®.

[28]  S. Tufik,et al.  Juvenile fibromyalgia: clinical and polysomnographic aspects. , 1997, The Journal of rheumatology.

[29]  M. Schouten,et al.  microRNAs and the regulation of neuronal plasticity under stress conditions , 2013, Neuroscience.

[30]  Y. Bayazıt,et al.  T102C polymorphism of the 5-HT2A receptor gene may be associated with temporomandibular dysfunction. , 2004, Oral diseases.

[31]  M. McDonagh,et al.  The American College of Rheumatology 1990 criteria for the classification of fibromyalgia , 2011 .

[32]  Thomas Meitinger,et al.  Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1 , 2010, Nature Genetics.

[33]  K. Ethans,et al.  Nabilone for the treatment of pain in fibromyalgia. , 2008, The journal of pain : official journal of the American Pain Society.

[34]  R. Carmi,et al.  Familial aggregation in the fihromyalgia syndrome , 1996 .

[35]  S. Sommer,et al.  Missense Mutations in the MEFV Gene Are Associated with Fibromyalgia Syndrome and Correlate with Elevated IL-1β Plasma Levels , 2009, PloS one.

[36]  J E Michalek,et al.  Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. , 1994, Arthritis and rheumatism.

[37]  R. Ebstein,et al.  An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits , 2004, Molecular Psychiatry.

[38]  Quality of life and physical functioning of relativesof fibromyalgia patients , 1997 .

[39]  A. Lu,et al.  Association of the cannabinoid receptor gene (CNR1) with ADHD and post‐traumatic stress disorder , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[40]  Myung-Gyu Choi,et al.  Cannabinoid Receptor 1 Gene Polymorphism and Irritable Bowel Syndrome in the Korean Population: A Hypothesis-generating Study , 2011, Journal of clinical gastroenterology.

[41]  W. Maixner,et al.  The phenotypic and genetic signatures of common musculoskeletal pain conditions , 2013, Nature Reviews Rheumatology.

[42]  Eric Bair,et al.  Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study. , 2011, The journal of pain : official journal of the American Pain Society.

[43]  B. Bondy,et al.  Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. , 1999, Arthritis and rheumatism.

[44]  S. Zingaretti,et al.  Serotonin receptor (5-HT 2A) and catechol-O-methyltransferase (COMT) gene polymorphisms: triggers of fibromyalgia? , 2010, Revista brasileira de reumatologia.

[45]  P. Montoya,et al.  Pain sensitivity in fibromyalgia is associated with catechol‐O‐methyltransferase (COMT) gene , 2013, European journal of pain.

[46]  D. Schmechel,et al.  Fibromyalgia, mood disorders, and intense creative energy: A1AT polymorphisms are not always silent. , 2012, Neurotoxicology.

[47]  J. Branco,et al.  HLA Studies in Fibromyalgia , 1996 .

[48]  H. Hermens,et al.  The Genetic Influence on the Cortical Processing of Experimental Pain and the Moderating Effect of Pain Status , 2010, PloS one.

[49]  G. Juhász,et al.  Variations in the cannabinoid receptor 1 gene predispose to migraine , 2009, Neuroscience Letters.

[50]  A. Holman,et al.  A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. , 2005, Arthritis and rheumatism.

[51]  N. Blau,et al.  Tetrahydrobiopterin biosynthesis, regeneration and functions. , 2000, The Biochemical journal.

[52]  D. Bartel,et al.  The impact of microRNAs on protein output , 2008, Nature.

[53]  J. Dimitrakov,et al.  Genetics and phenotyping of urological chronic pelvic pain syndrome. , 2009, The Journal of urology.

[54]  R. Ebstein,et al.  Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking , 1996, Nature Genetics.

[55]  W. Maixner,et al.  Three major haplotypes of the β2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[56]  K. Mannerkorpi,et al.  Profile of Cerebrospinal microRNAs in Fibromyalgia , 2013, PloS one.

[57]  W. Maixner,et al.  Genetic basis for individual variations in pain perception and the development of a chronic pain condition. , 2005, Human molecular genetics.

[58]  M. Schwarz,et al.  The T102C Polymorphism of the 5-HT2A-Receptor Gene in Fibromyalgia , 1999, Neurobiology of Disease.

[59]  K. Mannerkorpi,et al.  Profile of circulating microRNAs in fibromyalgia and their relation to symptom severity: an exploratory study , 2015, Rheumatology International.

[60]  M. Oakley,et al.  The many faces of the genetics contribution to temporomandibular joint disorder. , 2008, Orthodontics & craniofacial research.

[61]  B. Bondy,et al.  Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients , 2004, Clinical Rheumatology.

[62]  J. Lee,et al.  Association of Guanosine Triphosphate Cyclohydrolase 1 Gene Polymorphisms with Fibromyalgia Syndrome in a Korean Population , 2013, The Journal of Rheumatology.

[63]  G. Pedraza-Alva,et al.  Role of microRNAs in central nervous system development and pathology , 2012, Journal of neuroscience research.

[64]  Xutao Deng,et al.  Discovery of Potential New Gene Variants and Inflammatory Cytokine Associations with Fibromyalgia Syndrome by Whole Exome Sequencing , 2013, PloS one.

[65]  G. Waylonis,et al.  Familial occurrence of primary fibromyalgia. , 1989, Archives of physical medicine and rehabilitation.

[66]  F. D. de Serres,et al.  Estimated numbers and prevalence of PI*S and PI*Z alleles of α1-antitrypsin deficiency in European countries , 2006, European Respiratory Journal.

[67]  G. Miller,et al.  Trace amine-associated receptor 1 as a monoaminergic modulator in brain. , 2009, Biochemical pharmacology.

[68]  Blair H. Smith,et al.  Genome-wide association study meta-analysis of chronic widespread pain: evidence for involvement of the 5p15.2 region , 2012, Annals of the rheumatic diseases.

[69]  E. Nestler,et al.  Regulators of G-Protein Signaling (RGS) Proteins: Region-Specific Expression of Nine Subtypes in Rat Brain , 1997, The Journal of Neuroscience.

[70]  P. Dayer,et al.  Psychological distress in fibromyalgia patients: a role for catechol-O-methyl-transferase Val158met polymorphism. , 2012, Health Psychology.

[71]  H. Bağcı,et al.  Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility , 2008, Rheumatology International.

[72]  D. Buskila,et al.  Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. , 1997, The Journal of rheumatology.

[73]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[74]  I. Russell,et al.  Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. , 1992, Arthritis and rheumatism.

[75]  J. Lötsch,et al.  Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype , 2008, European journal of pain.

[76]  Lily Neumann,et al.  Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits. , 2002, Arthritis and rheumatism.

[77]  E. Madenci,et al.  Association of T102C polymorphism of the 5-HT2A receptor gene with pyschiatric status in fibromyalgia syndrome , 2001, Rheumatology International.

[78]  Enriching rare variants using family-specific linkage information , 2011, BMC proceedings.

[79]  Richard E. Harris.  Elevated excitatory neurotransmitter levels in the fibromyalgia brain , 2010, Arthritis Research & Therapy.